MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dopamine"

  • 2019 International Congress

    The dopamine receptor antagonist haloperidol enhances beta and gamma oscillations and bursts in the motor cortex

    M. Alam, T. Doll, J. Krauss, K. Schwabe (Hannover, Germany)

    Objective: We aimed to investigate the changes in oscillatory activity in the motor cortex (MCtx) and the sensorimotor cortex (SMCtx) of rats after acute injection…
  • 2019 International Congress

    Restless Leg Syndrome In Men: Examination Of Early Non-Motor Clinical Signs Of Parkinson’s Disease

    M. şenol, M. Karaoğlan, H. Tekeli (Istanbul, Turkey)

    Objective: Restless Legs Syndrome (RLS) is a disorder characterized by an abnormal sensation, some sort of dysesthesia, which cannot be described especially on the limbs.…
  • 2019 International Congress

    Brain neurotransmitters and neuropeptides alternations in Parkinson’s induced mouse models

    N. Kumar, R. Khanna (Jaipur, India)

    Objective: Present study aimed to investigate the changes in brain neurotransmitters and neuropetides in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse models  of PD. Background: Parkinson’s disease (PD), a…
  • 2019 International Congress

    Decreased serum alpha-synuclein in patients with Restless Legs Syndrome and association with SNCA-Rep1 polymorphism

    YC. Wu, XY. Zhu, TT. Wu, T. Liu, HM. Wang, YJ. Chen, X. Li, XX. Cui (Shanghai, China)

    Objective: To investigate whether α -synuclein levels are altered in serum and saliva in patients with RLS and explore influence of the SNCA-Rep1 microsatellite repeat…
  • 2019 International Congress

    Quercetin administration abrogates the Parkinson’s disease (PD)-like motor and non-motor symptoms and attenuates the behavioral, neurochemical and biochemical deficits induced by rotenone toxicity in rats

    S. Madiha, S. Haider (Karachi, Pakistan)

    Objective: The present study was carried out to investigate the preventive and therapeutic effects of quercetin (a flavonol) against rotenone-induced neurotoxicity. Background: Rotenone (pesticide) induced…
  • 2019 International Congress

    Movement Disorders in Post Stroke Patients: A Retrospective Analysis

    M. Christie, V. Laticevschi, R. Mehanna (Houston, TX, USA)

    Objective: To review the prevalence of various movement disorders in post stroke patients at a tertiary, academic center and to characterize the therapeutic response to…
  • 2019 International Congress

    How Parkinson’s Disease Affects Value-Based Decisions

    L. Montaser-Kouhsari, R. Gerraty, A. Bakkour, D. Shohamy (New York, NY, USA)

    Objective: Parkinson’s Disease (PD) is a degenerative motor disease that causes subtle deficits in decision-making as a result of striatal dysfunction due to dopamine depletion.…
  • 2019 International Congress

    Enhancing the Proteasomal Degradation of Alpha Synuclein: “The Hallmark” to attenuating the Progression of Parkinson’s Disease

    B. Adebisi, M. Adeleke (Osogbo, Nigeria)

    Objective: The research aimed at preventing the accumulation of Alpha Synuclein in order to prevent it's accumulation.  It is imperative that we also establish that…
  • 2019 International Congress

    Specific SLC6A3 variant shows association with better memory in PD patients longitudinally

    M. Ramezani, K. Martens, JS. Provost, I. Kathol, Z. Javer, J. Cheetham, E. Yoon, M. Kibreab, T. Hammer, ST. Lang, T. Alrazi, A. Robichaud, JR. Sarna, D. Martino, G. Pfeffer, O. Monchi (Calgary, AB, Canada)

    Objective: To study the effect of SLC6A3VNTR on PD patients’ cognition longitudinally. Background: Solute carrier family 6 neurotransmitter transporter dopamine member 3gene (SLC6A3) has two common…
  • 2019 International Congress

    Carrier Mediated Delivery System Bearing Dopamine for Effective Management of Parkinsonism

    M. Bhargava, S. Bhargava (Kanpur, India)

    Objective: In the present investigation, amino acid coupled liposomes bearing dopamine-HCl were prepared to deliver drug to the brain utilizing receptor-mediated transcytosis for effective management…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 26
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley